ARCHIVES

NCI Spent $381.2 Million On PR From 2006 to 2012, Vastly Outspending Other NIH, FDA Units

This article is from The Cancer Letter archive.

Vol. 39 No. 09 | March 1, 2013

Download PDF Visit The Full Archive

Related Articles

Five New Members Appointed To The National Cancer Advisory Board

July 8, 2011

North Central Group Review Postponed While New Committee Formed To Handle All “Regional: Groups

July 10, 1981

Most Older Men With Early Prostate Cancer Can Avoid Treatment, Analysis Finds

February 29, 2008

Gallo, Four Others Share Lasker Award

November 19, 1982

NCAB Subcommittee Approves Concept Of Qualifying Minimums, Salary Support Limit For Core Grants

October 3, 1980

FDA To Issue “Complete Response” Letters To Drug Sponsors.

July 11, 2008